Predictive and prognostic effect of ABO blood group on immune checkpoint inhibitors.
Ergun Y, Esen SA, Bardakci M, Ucar G, Kalkan Z, Urakci Z, Seyran E, Dogan M, Eren T, Aslan V, Kahraman S, Genc EE, Acikgoz Y, Dirikoc M, Esen I, Uncu D.
Ergun Y, et al. Among authors: dirikoc m.
Cancer Biomark. 2022;34(2):329-336. doi: 10.3233/CBM-210455.
Cancer Biomark. 2022.
PMID: 35001878